Conway Thomas E 4

Accession 0001628280-19-006932

CIK 0001314223other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 8:33 PM ET

Size

23.3 KB

Accession

0001628280-19-006932

Form 4

Period: 2019-05-13

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2019-05-13+4,843→ 63,177 total
Exercise/Conversion
Common Stock
2019-05-14$5.57/sh+36,740$204,642→ 126,637 total
Exercise/Conversion
Common Stock
2019-05-14$8.18/sh+41,279$337,662→ 246,666 total
Exercise/Conversion
Restricted Stock Units
2019-05-13−4,843→ 14,528 total
→ Common Stock (4,843 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2019-05-14−78,750→ 0 total
Exercise: $8.08From: 2016-02-19Exp: 2025-02-19→ Common Stock (78,750 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2019-05-14−41,279→ 0 total
Exercise: $8.18From: 2018-06-12Exp: 2027-06-12→ Common Stock (41,279 underlying)
Exercise/Conversion
Common Stock
2019-05-14$2.31/sh+26,720$61,723→ 89,897 total
Exercise/Conversion
Employee Stock Option (right to buy)
2019-05-14−26,720→ 0 total
Exercise: $2.31From: 2012-09-30Exp: 2021-09-30→ Common Stock (26,720 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2019-05-14−36,740→ 0 total
Exercise: $5.57From: 2014-06-25Exp: 2023-06-25→ Common Stock (36,740 underlying)
Exercise/Conversion
Common Stock
2019-05-14$8.08/sh+78,750$636,300→ 205,387 total
Sale
Common Stock
2019-05-14$12.95/sh−246,666$3,194,325→ 0 total

Footnotes (6)

[F1]On February 10, 2016, the reporting person was granted 77,487 RSUs, of which 1/16th vested on May 13, 2019. The remaining unvested RSUs will continue to vest as to 1/16th of the original number of shares subject to the RSUs on each succeeding quarter until fully vested on February 10, 2020.
[F2]Exercise and sale of 26,720 stock options from a 9/30/11 stock option grant, at an exercise price of $2.31 per share, with the exercise price and tax liability to be satisfied by sale proceeds.
[F3]Exercise and sale of 36,740 stock options from a 6/25/13 stock option grant, at an exercise price of $5.57 per share, with the exercise price and tax liability to be satisfied by sale proceeds.
[F4]Exercise and sale of 78,750 stock options from a 2/19/15 stock option grant, at an exercise price of $8.08 per share, with the exercise price and tax liability to be satisfied by sale proceeds.
[F5]Exercise and sale of 41,279 stock options from a 6/12/17 stock option grant, at an exercise price of $8.18 per share, with the exercise price and tax liability to be satisfied by sale proceeds.
[F6]Each RSU represents a contingent right to receive one share of common stock of the registrant.

Documents

1 file

Amber Road, Inc.

CIK 0001314223

Entity typeother